1
0
0
(1 - 32 von 37
)
Timothy Craig - | The Huck Institutes
www.huck.psu.edu
Timothy Craig, Henrike Feuersenger, Ingo Pragst, John Dang, 2022, New England and regional allergy proceedings on p › people
Verfasser Suchresultate
katalog.hfmdd.de
Treffer von 10 — ... Marc A. Riedl, Henrike Feuersenger, Subhransu Prusty, Ingo Pragst, Thomas Machnig, Timothy Craig, for the COMPACT Investigators › Author › Home
Download Figures (PPT) - The Lancet
www.thelancet.com
... MD, Prof Paul K Keith, MD, Paula Busse, MD, Henrike Feuersenger, PhD, Dipti Pawaskar, PhD, Iris Jacobs, MD, Ingo Pragst, PhD, Mittie K Doyle, MD. › journals › lancet › article
Long-term Safety of Subcutaneous C1-Inhibitor in the Prophylactic...
www.em-consulte.com
H. Henry Li, Timothy J. Craig, DO FAAAAI, Hilary Longhurst, Marco Cicardi, Henrike Feuersenger, Ingo Pragst, PhD, Sarah Mycroft, MD.
Eastern Allergy Conference August , 2020
img1.wsimg.com
Timothy Craig, Henrike Feuersenger, Ingo Pragst. Introduction: Hereditary angioedema (HAE) due to C1-inhibitor (C1-INH) deficiency is characterized by. › blobby › downloads
Long-term safety and efficacy of subcutaneous C1-inhibitor in ...
findresearcher.sdu.dk
von JA Bernstein · · Zitiert von: 3 — Henrike Feuersenger, PhD zz. ; Ingo Pragst, PhD zz. ; Marc A. Riedl, MD, MS xx. * Allergy Section, Division of Immunology, Department of Internal Medicine, ... › files › 1_s2.0_S10...
Prophylactic use of an anti-activated factor XII monoclonal ...
static1.squarespace.com
von T Craig · · Zitiert von: 15 — Bruce Ritchie, Emel Aygören-Pürsün, Paul K Keith, Paula Busse, Henrike Feuersenger, Dipti Pawaskar, Iris Jacobs, Ingo Pragst, Mittie K Doyle. › static › Prophyla...
Articles - Allergy, Asthma & Clinical Immunologyaacijournal.biomedcentral.com › articles
aacijournal.biomedcentral.com
... Jonathan Bernstein, Michael Manning, Donald Levy, Marc A. Riedl, Henrike Feuersenger, Subhransu Prusty, Ingo Pragst, Thomas Machnig and Timothy Craig.
OPUS 4 | Long-term outcomes with subcutaneous C1-inhibitor...
publikationen.ub.uni-frankfurt.de
· ... Donald Levy, Marc A. Riedl, Sandra Christiansen, Henrike Feuersenger, Ingo Pragst, Sarah Mycroft, Dipti Pawaskar, Iris Jacobs.
Long-term efficacy and safety of subcutaneous C1-inhibitor in women...
aacijournal.biomedcentral.com
von DS Levy · · Zitiert von: 10 — Henrike Feuersenger & Ingo Pragst. Allergy, Immunology and Angioedema Center, Barzilai Medical Center, Ashkelon, Israel. Avner Reshef. Authors: Donald S. Levy, Henriette Farkas, Marc A. Riedl, Florence Ida Hsu, Joel P. Brooks, Marco Cicardi, Henrike Feuersenger, Ingo Pragst and Avner Reshef. › ...
(PDF) Long-Term Safety of Subcutaneous C1-Inhibitor in the
research.amanote.com
Authors. H. Henry Li Timothy J. Craig Hilary Longhurst Marco Cicardi Henrike Feuersenger Ingo Pragst Sarah Mycroft. Publisher. Elsevier BV. Related search ... › lon...
The Journal of Allergy and Clinical Immunology: In Practice - ppt...
slideplayer.com
... MD, Henrike Feuersenger, PhD, Ingo Pragst, PhD, Sarah Mycroft, MD, Dipti Pawaskar, PhD, Iris Jacobs, MD The Journal of Allergy and Clinical Immunology: ... › slide
A phase I, first-in-human, randomized dose-escalation study of...
pubmed.ncbi.nlm.nih.gov
von A McKenzie — Authors. Andrew McKenzie , Anthony Roberts , Sourabh Malandkar , Henrike Feuersenger , Con Panousis , Dipti Pawaskar ... vor 2 Tagen — ... Emel Aygören-Pürsün , Paul K Keith , Paula Busse , Henrike Feuersenger , Dipti Pawaskar , Iris Jacobs , Ingo Pragst , Mittie K Doyle ... › ...
Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric ...
www.liebertpub.com
von D Levy · · Zitiert von: 3 — Henrike Feuersenger, PhD,9 Ingo Pragst, DVM, PhD,9 and Michael E. Manning, MD10. Background: Hereditary angioedema (HAE) due to C1 inhibitor (C1INH) ... › doi › pdf › ped
Presentation: Pharmacokinetic Profile of Subcutaneous C1-Esterase...
aaaai.confex.com
Dipti K. Pawaskar, PhD, Iris Jacobs, MD, Ingo Pragst, MD, Henrike Feuersenger, PhD. RATIONALE: Subcutaneous C1-INH (HAEGARDA®, CSL Behring) at
Pediatric Allergy, Immunology, and Pulmonology - fatcat.wiki
fatcat.wiki
... Avner Reshef, John Anderson, James Baker, Lawrence B Schwartz, Marco Cicardi, Subhransu Prusty, Henrike Feuersenger, Ingo Pragst, Michael E Manning. › container
ingo reidl facebook
ksfv.at
Donald S. Levy, 1 Henriette Farkas, 2 Marc A. Riedl, 3 Florence Ida Hsu, 4 Joel P. Brooks, 4 Marco Cicardi, 5 Henrike Feuersenger, 6 Ingo Pragst, ...
Prevention of hereditary angioedema attacks with a subcutaneous ...
cris.tau.ac.il
... Debra Bensen-Kennedy, Jonathan Edelman, Henrike Feuersenger, John Philip Lawo, Thomas MacHnig, Dipti Pawaskar, Ingo Pragst, Bruce L. Zuraw. › fingerprints
Prophylactic therapy with subcutaneous C1-inhibitor Ebsco
search.ebscohost.com
von T Craig · · Zitiert von: 1 — Timothy Craig, D.O.,1 Henrike Feuersenger, Ph.D.,2 Ingo Pragst, D.V.M., Ph.D.,2 and. John Dang, Pharm.D.3. ABSTRACT. Background: Hereditary angioedema (HAE) ... › login
Prophylactic therapy with subcutaneous C1-inhibitor is associated ...
www.semanticscholar.org
author={Timothy Craig and Henrike Feuersenger and Ingo Pragst and Johnny Dang}, journal={Allergy and asthma proceedings}, year={2022}, volume={43 3}, ... › ...
Effects of Continuous Plasma-Derived Subcutaneous C1-Esterase...
pennstate.pure.elsevier.com
· ... Marco Cicardi, Timothy Craig, Paul K. Keith, Annette Feussner, Henrike Feuersenger, Thomas Machnig, Subhransu Prusty, Ingo Pragst.
MOESM1 of Subcutaneous C1 inhibitor for prevention of attacks of...
figshare.com
· ... Donald Levy, Marc Riedl, Henrike Feuersenger, Subhransu Prusty, Ingo Pragst, Thomas Machnig, Timothy Craig. Additional file 1: Table S1.
Presentation: Long-term Safety of Subcutaneous C1-Inhibitor in the...
aaaai.confex.com
· H. Henry Li, Timothy J. Craig, DO FAAAAI, Hilary Longhurst, Marco Cicardi, Henrike Feuersenger, Ingo Pragst, PhD, Sarah Mycroft, MD.
a randomised, double-blind, placebo-controlled, phase 2 trial
pubmed.ncbi.nlm.nih.gov
von T Craig · · Zitiert von: 14 — ... Emel Aygören-Pürsün , Paul K Keith , Paula Busse , Henrike Feuersenger , Dipti Pawaskar , Iris Jacobs , Ingo Pragst , Mittie K Doyle ... › ...
krankheitslast und psychische komorbiditäten bei patienten ...
ul.qucosa.de
von M Rabe — Henrike Feuersenger, Subhransu Prusty, Ingo Pragst, Thomas Machnig, and Timothy. Craig “Subcutaneous C1 Inhibitor for Prevention of Attacks of ... › api › attachment › ATT-0
35th ICPE Final Program
www.pharmacoepi.org
— Ami S Patel, Henrike Feuersenger,. Sarah Mycroft, Ingo Pragst,. Daniel Wood, Thomas Machnig,. Douglas Watson. (United States). › pub
Prophylactic therapy with subcutaneous C1-inhibitor is PubMedpubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
· Authors. Timothy Craig , Henrike Feuersenger , Ingo Pragst , John Dang. Affiliations. 1 From the Department of Medicine, Pediatrics and ...
Presentation: Health-Related Quality of Life (HRQoL) and Changes in...
aaaai.confex.com
— William Lumry, Timothy J. Craig, DO FAAAAI, Henriette Farkas, Henrike Feuersenger, Douglas Watson. Rationale: HAE has been associated with — ... Timothy J. Craig, DO FAAAAI, Avner Reshef, MD, Henriette Farkas, Henrike Feuersenger, Daniel Wood, PhD, Douglas Watson, Ingo Pragst, PhD. › aaaai
Article - Prophylactic use of an anti-activated factor XII Scilit
www.scilit.net
— Paul K Keith, Paula Busse, Henrike Feuersenger, Dipti Pawaskar, Iris Jacobs, Ingo Pragst, Mittie K Doyle. Show More. › article
Prophylactic use of an anti-activated factor XII monoclonal antibody ...www.scilit.net › article
www.scilit.net
· Paul K Keith, Paula Busse, Henrike Feuersenger, Dipti Pawaskar, Iris Jacobs, Ingo Pragst, Mittie K Doyle. Show More.
Alle Infos zum Namen "Henrike Feuersenger"
Verwandte Suchanfragen zu Henrike Feuersenger
| Paula Busse Henriette Farkas Sarah Mycroft | Ingo Pragst Marc Riedl Thomas Machnig | John Dang Lilian Varga Dong-In Shin |
Person "Feuersenger" (3) Vorname "Henrike" (2071) Name "Feuersenger" (107) |
sortiert nach Relevanz / Datum